Go to main contents

Announcement

Official announcement on the international collaborative research program for high-risk viruses, focusing on viral hemorrhagic fevers

Update 09.11.2026

Official announcement on the international collaborative research program for high-risk viruses, focusing on viral hemorrhagic fevers

 

Sponsored by the Korea National Institute of Health (KNIH), KDCA

 

[Preface]

The Korea National Institute of Health (KNIH), a national research institute under the Korea Disease Control and Prevention Agency (KDCA), is committed to advancing global public health through research on infectious and non-infectious diseases. Recurrent outbreaks of Ebola virus in Africa, and the potential for cross-border spread continue to threaten national health security. Limited therapeutic options for these viral hemorrhagic fevers highlight the need for validated evaluation systems and sustained international cooperation.

 

In line with this need, KNIH seeks to establish collaborative research framework through partnership with leading institution. This program will support the development and validation of biologically contained antiviral evaluation systems for the target viruses, together with sharing of relevant research resources and technical training as a joint research activity. These activities will strengthen national research capacity responding to next outbreaks or pandemics and provide a foundation for a sustainable research partnership.

 

[Project Schema]

1.Project Title

Establishment of an International Research Collaboration for Antiviral Development against High-Risk Viruses

 

2. Funding

The selected institution will provide KRW 100,000,000 (approximately USD 75,000*) for the project period.

(Note) The final budget will be adjusted with the results of reviewer’s comments.

* The equivalent amount in US dollars may vary depending on the applicable exchange rate.

 

3. Research Period: After contract 2026 – August 2027

From the date of execution of the Research agreement in 2026 to August 31, 2027

 

4. Objectives and Key Research Activities

The project aims to develop and validate antiviral screening and evaluation systems for high-risk viruses, focusing on viral hemorrhagic fevers, and support its implementation at KNIH through research resources sharing and technical cooperation.

 

● Development of Antiviral Screening and Evaluation System

- (Target Pathogen) Ebola/ Bundibugyo virus, focusing on a recent outbreak strain

 

* Note: Depending on research progress, platform development may be expanded to additional pathogens in consultation with KNIH, with Lassa virus as the highest-priority candidate. Such expansion will be subject to feasibility within the available budget and timeframe;

 

 

- (Platform) Develop biologically contained evaluation resources and establish an antiviral screening and evaluation platform for the target pathogen, utilizing existing institutional platforms where appropriate.

 

 

● Platform optimization and Validation

Optimize and validate the platform using reference compounds with established antiviral activity, and provide SOPs, and validation date

 

* If feasible within budget and timeframe, and in consultation with KNIH, it could be considered to screen a limited number of compounds using the validated system.

 

 

● Sharing research resources and technical cooperation

Provide agreed assay-related materials and research resources, protocol and SOPs that are designed within this project, under applicable MTAs under agreement between two institutions

 

* If would be feasible, support technical training for implementation of this system at KNIH

 

5. Affiliation: Government Institute, Research Institute, University, Hospital, etc

 

6. Submission and Reporting

Format: Applications must be written in English using MS Word.

Deadline: All applications must be submitted via e-mail by November 20, 2026.

 

< Contact >

e-mail : yms37@korea.kr (In case of emergency condition; limhy0919@korea.kr)

 

Division of Emerging virus & Vector Research

Center for Emerging Virus Research, National Institute of Health

Korea Centers for Disease Control and Prevention

 

187, Osongsaengmyeong 2-ro, Cheongju-si,

Chungcheongbuk-do 28159, South Korea

 

TEL : +82-43-719-8510

 

 • KNIH Program Proposal(Form)

connect